This study did not find any evidence that the use of CRP POCT in RTI (lower RTI, bronchitis, chest/respiratory infection and cough) leads to a statistically significant decrease in the total antibiotic prescribing rate in adults older than 18 and younger than 65 years in practices with high antibiotic prescribing rates. This evidence concerns the gene CRP and respiratory tract infectious disorder.